ARX
AROA BIOSURGERY LIMITED
$0.5000
▼ -0.99%
Market cap
$173M
Turnover
$116,481
Last price
$0.5000
Day change
-0.99%
Announcements
7
Range, past year
Open 0.710 · Low 0.427 · Now 0.500 · High 0.800
Open ARX in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
ARX momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
29/100
Wyckoff phase
Accumulation5d
Trend stage
Neutral
1 Day
-1.0%
1 Week
+0.0%
1 Month
-9.9%
1 Year
-29.6%
RSI
43
Avg daily range
5.0%
AROA BIOSURGERY LIMITED scores 29 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 5 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- Risk rating: High
- Composite downside risk elevated
ARX announcements
Recent price-sensitive releases.
- 2026-10-05 Symphony Significantly Improves DFU Healing Progress Report
- 2026-05-26 FY26 Full Year Results Presentation
- 2026-05-26 FY26 Appendix 4E and Full Year Results
- 2026-04-30 ARX FY26 Preliminary Results
More Health Care stocks
Most traded in the same sector.